TM4SF5 might thus be an NK cell immune checkpoint, and that treatment of TM4SF5-specific isoxazole-based small molecules (TSIs) recovered NK cell cytotoxicity, leading to abrogated HCC. This evidence concerns the gene TM4SF5 and hepatocellular carcinoma.